Skip to main content
logo
Ascendis Pharma A/S (FRA:A71)
Germany flag Germany · Delayed Price · Currency is EUR
206.00
+2.00 (0.98%)
Inactive · Last trade price on Apr 17, 2026

Ascendis Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Last Close Price
206.00177.00132.00115.00113.00117.00

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Debt / Equity Ratio
-5.35-5.35-8.10-4.421.930.12
Debt / FCF Ratio
19.2019.20----
Net Debt / Equity Ratio
-1.57-1.57-2.81-1.68-0.89-0.77
Net Debt / EBITDA Ratio
-1.95-1.95-1.08-0.560.431.57
Net Debt / FCF Ratio
5.635.63-0.97-0.520.461.55
Asset Turnover
0.580.580.360.280.050.01
Inventory Turnover
0.320.320.180.260.12-
Quick Ratio
0.720.720.810.621.067.03
Current Ratio
1.041.041.170.951.298.03
Return on Equity (ROE)
----818.43%-101.69%-44.54%
Return on Assets (ROA)
-6.86%-6.86%-17.38%-29.73%-32.29%-27.35%
Return on Capital Employed (ROCE)
-58.40%-58.40%-102.60%-511.40%-150.60%-45.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Buyback Yield / Dilution
-4.69%-4.69%-2.85%-0.38%-2.37%-8.21%